Advanced Cell Diagnostics Scores $12 Million in Financing

Advanced Cell Diagnostics Inc. has completed a $12 million Series B equity financing. Healthcare technology venture capital firm New Leaf Venture Partners and existing investor Morningside Ventures participated in the round.

Proceeds from the financing will be used to support the commercial expansion of the company's proprietary RNAscope‐based products and services into the life science research market and accelerate the entry of RNAscope into the clinical diagnostics market.

The announcement was made in a press release.

Ivdt insight blog Tags: